Diversify Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Diversify Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.41M	Buy	22,232 +10,542	+90%	+$4.92M	0.17%	134
2025 Q4	$5.32M	Sell	11,690 -524	-4%	-$226K	0.25%	108
2025 Q3	$5.2M	Sell	12,214 -774	-6%	-$323K	0.3%	96
2025 Q2	$5.04M	Buy	12,988 +1,976	+18%	+$911K	0.31%	86
2025 Q1	$5.54M	Buy	11,012 +1,239	+13%	+$577K	0.41%	60
2024 Q4	$4M	Buy	9,773 +6,027	+161%	+$2.79M	0.31%	87
2024 Q3	$1.76M	Buy	3,746 +800	+27%	+$384K	0.17%	149
2024 Q2	$1.4M	Buy	+2,946	New	+$1.28M	0.17%	130

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Diversify Wealth Management's VRTX Position: Q1 2026 in Review

Diversify Wealth Management increased its Vertex Pharmaceuticals (VRTX) stake by 90% in Q1 2026, buying an estimated $4.92M and bringing the position to 22,232 shares worth $9.41M. The position accounts for 0.17% of the portfolio, ranked #134.

Diversify Wealth Management first reported a position in VRTX in Q2 2024 and has held it in 8 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Diversify Wealth Management held 22,232 shares of Vertex Pharmaceuticals worth $9.41M as of Q1 2026.
Diversify Wealth Management bought 10,542 Vertex Pharmaceuticals shares in Q1 2026, an estimated $4.92M.
Vertex Pharmaceuticals made up 0.17% of Diversify Wealth Management's portfolio in Q1 2026, its #134 holding.
Diversify Wealth Management first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Diversify Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.